Privileged access management market leader CyberArk has announced the $1.54bn acquisition of non-human identity (NHI) management vendor Venafi.
OM122138
Email Article
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.
CyberArk dives into NHI with $1.54bn Venafi acquisition
An error occured. Please try again later
You are now following this Analyst
You unfollowed this Analyst
The Analyst Team
Rik Turner
Follow AnalystChief Analyst, Cybersecurity
Rik Turner is a chief analyst in Omdia’s cybersecurity team, covering emerging cybersecurity technology trends across all the areas the team researches.
Rik has also worked in Omdia’s financial services technology team, with a specialization in capital markets technology. Prior to joining Informa, he worked as an IT journalist, specializing in networking and security. He was also a foreign correspondent in Brazil, where he worked, among others, for the Financial Times and The Economist.
More Content By Rik Turner
Become A Client
Find out more about our full suite of products and solutions.
Become A ClientYou must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
These are Omdia driven recommendations based on content that is both similar, and has been frequently visited by other users in combination with the content you are currently viewing.
Omdia Recommends
These are Omdia driven recommendations based on content that is both similar, and has been frequently visited by other users in combination with the content you are currently viewing.
Thank you
Our expert analysts will review your question and the Ask an Analyst team will get back to you. We aim to respond within 24 hours, but we’re often quicker.
Ask an Analyst
Our team of experts are here to answer your questions. From advice on market trends to a query on research point, and everything in between, we want to hear from you.
Ask an analyst is available as part of a subscription. If you'd like access, contact us today.